key: cord-0806683-ofcc1c65 authors: Mak, Gannon CK; Cheng, Peter KC; Lau, Stephen SY; Wong, Kitty KY; Lau, CS; Lam, Edman TK; Chan, Rickjason CW; Tsang, Dominic NC title: Evaluation of rapid antigen test for detection of SARS-CoV-2 virus date: 2020-06-08 journal: J Clin Virol DOI: 10.1016/j.jcv.2020.104500 sha: 75dbc1de68f6e09a13a21429541554dfee937c67 doc_id: 806683 cord_uid: ofcc1c65 BACKGROUND: The rapid diagnosis of COVID-19 patients is essential to reduce the disease spread. Rapid antigen detection (RAD) tests are available, however, there is scanty data on the performance of RAD tests. OBJECTIVE: To evaluate the performance of BIOCREDIT COVID-19 Ag test and compared it with real-time RT-PCR for detecting SARS-CoV-2 virus. Study Design: Analytical sensitivity for the detection of SARS-CoV-2 virus was determined for the RAD test using viral culture and PCR as a reference methods. The RAD test was further evaluated using respiratory samples collected from confirmed COVID-19 patients. The results were compared with RT-PCR test. RESULTS: The detection limits between RAD test, viral culture and PCR varied hugely. RAD was 103 fold less sensitive than viral culture while RAD was 105 fold less sensitive than RT-PCR. The RAD test detected between 11.1% and 45.7% of real-time RT-PCR-positive samples from COVID-19 patients. CONCLUSIONS: This study demonstrated that the RAD test serve only as adjunct to RT-PCR test because of potential for false-negative results. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of coronavirus belonging to the genus β. On 11 Mar 2020, World Health Organization (WHO) declared Coronavirus disease 2019 (COVID-19) as a pandemic. 1 Viral culture and PCR are the gold standards in the diagnosis of SARS-CoV-2 infection. 2 However, it takes hours to detect the nucleic acid and days to isolate the virus. In addition, specialized instrument and expertise is required. For rapid diagnosis of SARS-CoV-2 infection, rapid antigen detection (RAD) tests for qualitative determination of SARS-CoV-2 antigen are available. RAD tests detect viral antigen by the immobilized coated SARS-CoV-2 antibody on the device. The test results of RAD can be interpreted without specialized instrument and available within 30 minutes. Hence, RAD tests can relieve the workload in diagnostic hospitals and laboratories and improve the turnaround time. However, according to WHO the role of RAD tests for antigen detection for SARS-COV-2 needs to be evaluated and is not recommended for clinical diagnosis. 3 The purpose of this evaluation is to assess the diagnostic use of the commercially available BIOCREDIT COVID-19 Ag test. The aim of the first part of the study was to assess the limit of detection (LOD) between RAD test, RT-PCR and viral culture and the second part was to evaluate performance of RAD test in detecting SARS-CoV-2 virus in different types of respiratory specimens. The SARS-CoV-2 culture isolate (strain hCoV-19/Hong Kong/VM20001097/2020, the first SARS-CoV-2 case detected in Hong Kong) was used to perform a serial tenfold dilution to determine LOD between different assays. We evaluated the only commercially available RAD kit in Hong Kong at the time of starting the evaluation, BIOCREDIT COVID-19 Ag for the diagnosis of SARS-CoV-2 infection. The intended use for BIOCREDIT COVID-19 Ag kit is for nasopharyngeal swab specimen. As NPA & TS, NPS & TS, sputum and throat saliva had either been eluted in VTM or suspended in PBS, the test was carried out with modified sample processing methods. The recommended sample volume by the BIOCREDIT COVID-19 Ag kit was 90-150 uL. To unify the sample volume, 100 uL sample volume was used. We evaluated two sample processing methods based on the nature of the samples. For less viscous samples These samples do not need preparation, 100 uL sample was added directly into a sample well of the device. The swab provided by the kit was used to collect the samples and the swab was immersed in the provided assay diluent tube. The subsequent procedures were carried out according to the manufacturer's instructions. In an effort to compare the performance of two sample processing methods (i.e. methods for handling less viscous and viscous samples), LOD was determined using a serial tenfold dilution of virus. The results were then compared with RT-PCR and viral culture. J o u r n a l P r e -p r o o f The LOD of the RAD test was 1000 fold less sensitive than viral culture when 100 uL sample was added directly into a sample well of the device (RAD: 10 -2 ; viral culture: 10 -5 ). PCR is the most sensitive assay for detecting SARS-CoV-2 virus (10 -7 ). For the RAD test, there were marked differences in sensitivity when using the provided swab to transfer the sample to the assay diluent tube and then adding 100 uL of the suspension into a sample well. The fold difference between two RAD sample processing method was at least 100 fold (Table 1) . It seemed to be related to the volume of sample used and the dilution effect in the assay diluent tube. As shown in Table 1 (Figure 1 ). The RAD test detected between 28.6% and 81.8% of real-time RT-PCR-positive high viral load samples from COVID-19 patients. However, it only detected between 0-21.1% for normal viral load samples. In the cross-reactivity test using virus isolates, all were tested negative by the RAD test. In this study, we determined the performance characteristics of the RAD test, the The limitations of this study include the fact that we employed a modified sample processing method to perform the RAD test. We added some sample directly into a sample well of the device instead of using the swab provided by the kit to collect the samples, immerse the swab in the provided assay diluent tube and add the suspension into a sample well of the device. However, we were capable of determining the viral load dependent effect on its sensitivity. J o u r n a l P r e -p r o o f WHO. Coronavirus disease (COVID-2019) Situation Report -51 Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance WHO. Laboratory testing strategy recommendations for COVID-19: interim guidance WHO. WHO reference laboratories providing confirmatory testing for COVID-19 Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis Laboratory diagnosis of swine flu: a review Figure 1. The results of the 160 respiratory samples tested for RAD test and the corresponding Ct values of SARS-CoV-2 virus-specific real-time RT-PCR We thank all staff of the Microbiology Division, Public Health Laboratory Services Branch, and Communicable Disease Branch, Centre for Health Protection, for technical assistance and epidemiological information during the current SARS CoV-2 pandemic. None.